Moderna Reports Q1 Revenue Drop Amid Lower Covid Vaccine Demand, Exceeds Loss Expectations
Moderna Inc. reported a 35% drop in Q1 revenues to $108 million, but beat Wall Street estimates, with a net loss of $971 million, as the company navigates the post-pandemic landscape.
2 minutes to read